LENZ Chart
See on advanced chart >
About
Lenz Therapeutics, Inc. was registered in Ontario, Canada on June 1, 2017, and re-registered in Delaware in October 2019. They are a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new...
Read More
- HighlightA clinical late-stage biopharmaceutical company focused on developing innovative ophthalmic drugs for the treatment of presbyopia
- ExchangeNASDAQ
- Listing Date06/25/2021
- Established Date06/01/2017
- Full-time Employees6
- Address445 Marine View Ave. Ste. #320 Del Mar California 92014
- Tel1-858-9257000
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Biotechnology